Skip to main content

COVID-19 Advisory: Visitor restrictions are in place for all Phoenix Children’s locations. Masks are required for all visitors and for patients ages 2+. For more information, visit our COVID-19 Resource Center.

Dorothee K. Newbern, MD

Edit Profile

Dorothee K. Newbern, MD

Edit Profile

Specialty

Areas of Expertise

  • Pediatrics Ped. Endocrinology

Locations

Phoenix Children's Medical Group - Endocrinology

1920 E Cambridge Ave
Phoenix, AZ 85006-1464
United States

Get Driving Directions

Phoenix Children's Medical Group - Endocrinology (Main)

1919 E Thomas Rd
Phoenix, AZ 85016-7710
United States

Get Driving Directions

About Dorothee K. Newbern, MD

Born and raised in France, Dr. Newbern moved to the United States as a teenager. She earned a B.S in biology from Duke University, then attended medical school at Wake Forest University School of Medicine. Following graduation from medical school, she completed her Pediatric Residency and Pediatric Endocrinology Fellowship training at Duke Medical Center, where she remained on faculty until joining the PCH Endocrinology Division in 2013. At PCH, Dr. Newbern has been heavily engaged in medical education. She is currently an Associate Program Director of the combined Phoenix Children's Hospital and Maricopa Medical Center Pediatric Residency Program. Her research interests include obesity, insulin resistance, and diabetes. Outside of work, Dr. Newbern enjoys cooking, jogging, traveling, and taking care of her two daughters.

+Education & Training

Board Certification

Pediatric Endocrinology

Medical School / Education

Wake Forest School of Medicine, Winston Salem, NC

Residency

Duke University Medical Center, Durham, NC

Fellowship

Duke University Medical Center, Durham, NC

+Academic and Professional Affiliations

Academic Affiliations

University of Arizona Phoenix College of Medicine

Professional Affiliations

Endocrine Society, Pediatric Endocrine Society

+Research & Publications

1.Janiel Pimentel, Chirag Kapadia, Dorothee Newbern and Gabriel Shaibi. Adrenal Suppression Secondary to Interaction of Combined Inhaled Corticosteroid and Antifungal Agent. AACE Clin Case Rep. Jul 2018, Vol. 4, No. 4 (July/August 2018) pp. e305-e308.2.Melissa A. Chambers, Theresa A. Grebe, and Dorothee K.D. Newbern. Two cases of 22q11 Deletion Syndrome and Type 1 Diabetes. AACE Clin Case Rep. May 2018, Vol. 4, No. 3 (May/June 2018) pp. e209-e212.3.Gkourogianni A, Andrew M, Tyzinski L, Crocker M, Douglas J, Dunbar N, Fairchild J, Funari MF, Heath KE, Jorge AA, Kurtzman T, LaFranchi S, Lalani S, Lebl J, Lin Y, Los E, Newbern D, Nowak C, Olson M, Popovic J, Pruhova S, Elblova L, Quintos JB, Segerlund E, Sentchordi L, Shinawi M, Stattin EL, Swartz J, Ariadna GA, Sinhue DC, Hosono H, Sanchez-Lara PA, Hwa V, Baron J, Nilsson O, Dauber A. Clinical characterization of patients with autosomal dominant short stature due to aggrecan mutations. J Clin Endocrinol Metab. 2017 February, 102(2):460-469.4.Hinson A, Newbern D, Linardic C. Asparaginase-Induced Hypertriglyceridemia Presenting as Pseudohyponatremia during Leukemia Treatment. Case Rep Pediatr. 2014; 2014: 635740.5.Newbern D, Gumus-Balikcioglu P, et. al. Sex Differences in Biomarkers Associated with Insulin Resistance in Obese Adolescents: Metabolic Profiling and Principal Component Analysis. J Clin Endocrinol Metab. 2014 Dec; 99(12):4730-9.6.Irizarry K, Newbern D, Freemark M. Chapter 19: Endocrinopathies of the Preterm Infant. William F. Malcolm, ed. Beyond the NICU: Comprehensive Care of the High Risk Infant. New York, NY, August 2014: The McGraw-Hill Companies.7.Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes. 2011 Dec;18(6):409-16. Review.8.Newbern, D.K. A neonate with autosomal recessive pseudohypoaldosteronism type 1. Endo Trends, 2010; 17 (1): 7-9.
Share this page